Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Ally Financial reports Q3 results on October 20 against a backdrop of rising short interest, a wave of analyst target cuts, and a stock that has lost nearly 10% over the past month.
Short sellers have been adding positions at a meaningful pace. Short interest climbed 21% over the past month to reach just over 5% of the free float, with the bulk of that move coming in a step-change around October 8. Days to cover stand at roughly four, a modest but not trivial cushion for bears. The borrow market itself offers little resistance to further shorting: availability is exceptionally loose at nearly 5,900%, meaning there are far more shares available to lend than are currently borrowed. Borrowing costs have also dropped sharply, down 37% over the past week to just 0.28%. This is not a crowded or expensive short. Options positioning, meanwhile, has tilted in the opposite direction. The put/call ratio of 0.80 is running about 1.7 standard deviations below its 20-day average, suggesting call buying has picked up relative to puts. That divergence between rising short interest and call-heavy options flow is the central tension heading into the print.
The analyst community has been almost uniformly cutting targets in the weeks ahead of results, though most retain positive ratings. Morgan Stanley was the notable exception: Betsy Graseck downgraded from Overweight to Equal-Weight on October 12, trimming the target from $55 to $43, just days before the print. Wells Fargo made a similar move to Equal-Weight late in September. JPMorgan, RBC, Raymond James, TD Cowen, UBS, and Citigroup all maintained constructive ratings while lowering targets, nearly all from the $54 to $58 range down to the low $50s. The consensus mean target now stands at $48.78, implying roughly 29% upside from the current $37.68, though the breadth of downward revisions signals Street discomfort with the near-term numbers. Bulls point to the stability of the $83.9 billion consumer auto loan book and a firming margin outlook. Bears focus on the shrinking commercial auto portfolio, the sequential decline in net financing revenues, and the credit quality risk that comes with concentrated auto exposure.
Two ORTEX Alt Data datasets are being tracked against Ally's reported figures: FDIC call reports (published by the Federal Deposit Insurance Corporation) and SEC EDGAR ABS trustee consumer credit filings. Neither has yet been measured as a leading indicator of the quarterly print, both lack sufficient history for a statistically valid backtest. The FDIC data does carry a notable reading: total deposits hit their largest Q2 on record since 2024, and total assets have grown for four consecutive quarters through the period ending June 2026. Those facts speak to balance-sheet momentum but cannot be read as forward guidance for the October print. Separately, Ally's ABS trust delinquency rate ranks in roughly the 26th percentile against other reporting trusts as of late September, below the median but not at an alarming extreme.
Among closely correlated peers, Capital One, OneMain Financial, and Synchrony all rose more than 2% on Thursday while ALLY slipped fractionally. That relative underperformance on a day when the consumer finance group broadly gained underlines the stock-specific caution investors are carrying into Monday's release. The October 20 print will test whether the margin improvement the bull case depends on is materialising fast enough to justify a valuation that, at 6.4 times trailing earnings and 0.75 times book, already prices in considerable credit stress.
See the live data behind this article on ORTEX.
Open ALLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
